Royal Bank of Canada
NVO

Royal Bank of Canada’s Novo Nordisk NVO Stock Holding History

Royal Bank of Canada’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166M Buy
4,527,779
+141,376
+3% +$6.7M 0.03% 457
2025
Q4 		$223M Sell
4,386,403
-351,262
-7% -$18M 0.04% 382
2025
Q3 		$263M Sell
4,737,665
-350,629
-7% -$20.5M 0.04% 352
2025
Q2 		$351M Sell
5,088,294
-357,992
-7% -$24.4M 0.06% 266
2025
Q1 		$378M Sell
5,446,286
-14,447
-0.3% -$1.19M 0.08% 226
2024
Q4 		$470M Sell
5,460,733
-543,387
-9% -$58.8M 0.09% 186
2024
Q3 		$715M Buy
6,004,120
+102,132
+2% +$13.6M 0.15% 134
2024
Q2 		$842M Buy
5,901,988
+405,231
+7% +$53.7M 0.19% 95
2024
Q1 		$706M Buy
5,496,757
+1,722,038
+46% +$205M 0.16% 117
2023
Q4 		$390M Buy
3,774,719
+131,658
+4% +$13M 0.09% 196
2023
Q3 		$331M Buy
3,643,061
+388,597
+12% +$34.2M 0.09% 198
2023
Q2 		$263M Buy
3,254,464
+92,120
+3% +$7.53M 0.07% 253
2023
Q1 		$252M Sell
3,162,344
-305,482
-9% -$21.7M 0.07% 248
2022
Q4 		$235M Buy
3,467,826
+6,260
+0.2% +$367K 0.07% 258
2022
Q3 		$172M Sell
3,461,566
-191,134
-5% -$10.2M 0.05% 294
2022
Q2 		$204M Buy
3,652,700
+23,548
+0.6% +$1.31M 0.06% 269
2022
Q1 		$202M Buy
3,629,152
+42,740
+1% +$2.19M 0.05% 303
2021
Q4 		$201M Buy
3,586,412
+198,708
+6% +$10.8M 0.05% 326
2021
Q3 		$163M Buy
3,387,704
+125,658
+4% +$6.07M 0.04% 355
2021
Q2 		$137M Buy
3,262,046
+128,414
+4% +$4.98M 0.04% 394
2021
Q1 		$106M Buy
3,133,632
+176,658
+6% +$6.29M 0.03% 445
2020
Q4 		$103M Buy
2,956,974
+128,242
+5% +$4.43M 0.03% 448
2020
Q3 		$98.2M Sell
2,828,732
-16,178
-0.6% -$539K 0.04% 395
2020
Q2 		$93.1M Buy
2,844,910
+103,794
+4% +$3.31M 0.04% 381
2020
Q1 		$82.5M Sell
2,741,116
-218,782
-7% -$6.51M 0.04% 345
2019
Q4 		$85.7M Sell
2,959,898
-192,380
-6% -$5.33M 0.03% 427
2019
Q3 		$81.5M Buy
3,152,278
+95,424
+3% +$2.41M 0.03% 423
2019
Q2 		$78M Sell
3,056,854
-120,696
-4% -$2.98M 0.03% 426
2019
Q1 		$83.1M Buy
3,177,550
+120,948
+4% +$2.97M 0.04% 398
2018
Q4 		$70.4M Buy
3,056,602
+71,662
+2% +$1.59M 0.03% 421
2018
Q3 		$70.4M Buy
2,984,940
+423,890
+17% +$10.3M 0.03% 463
2018
Q2 		$59.1M Buy
2,561,050
+177,892
+7% +$4.23M 0.03% 490
2018
Q1 		$58.7M Buy
2,383,158
+79,872
+3% +$2.1M 0.03% 512
2017
Q4 		$61.8M Buy
2,303,286
+155,386
+7% +$3.95M 0.03% 513
2017
Q3 		$51.7M Sell
2,147,900
-153,704
-7% -$3.47M 0.02% 546
2017
Q2 		$49.4M Buy
2,301,604
+47,356
+2% +$956K 0.03% 543
2017
Q1 		$38.6M Buy
2,254,248
+161,650
+8% +$2.81M 0.02% 642
2016
Q4 		$37.5M Buy
2,092,598
+176,650
+9% +$3.2M 0.02% 664
2016
Q3 		$39.8M Buy
1,915,948
+215,142
+13% +$5.33M 0.02% 602
2016
Q2 		$45.7M Buy
1,700,806
+68,826
+4% +$1.89M 0.03% 516
2016
Q1 		$44.2M Buy
1,631,980
+42,976
+3% +$1.15M 0.03% 505
2015
Q4 		$46.1M Buy
1,589,004
+269,388
+20% +$7.46M 0.03% 477
2015
Q3 		$35.8M Sell
1,319,616
-107,992
-8% -$3.06M 0.03% 488
2015
Q2 		$39.1M Sell
1,427,608
-70,152
-5% -$1.97M 0.03% 480
2015
Q1 		$40M Buy
1,497,760
+48,844
+3% +$1.12M 0.03% 478
2014
Q4 		$30.7M Buy
1,448,916
+78,926
+6% +$1.76M 0.02% 631
2014
Q3 		$32.6M Buy
1,369,990
+155,120
+13% +$3.57M 0.02% 558
2014
Q2 		$28.1M Buy
1,214,870
+22,910
+2% +$506K 0.02% 616
2014
Q1 		$27.2M Sell
1,191,960
-88,980
-7% -$1.9M 0.02% 601
2013
Q4 		$23.7M Buy
1,280,940
+367,020
+40% +$6.4M 0.02% 708
2013
Q3 		$15.5M Buy
913,920
+99,220
+12% +$1.67M 0.01% 880
2013
Q2 		$12.6M Buy
+814,700
New +$13.6M 0.01% 926

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Royal Bank of Canada's NVO Position: Q1 2026 in Review

Royal Bank of Canada increased its Novo Nordisk (NVO) stake by 3.2% in Q1 2026, buying an estimated $6.7M and bringing the position to 4,527,779 shares worth $166M. The position accounts for 0.03% of the portfolio, ranked #457.

Royal Bank of Canada first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $842M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Royal Bank of Canada held 4,527,779 shares of Novo Nordisk worth $166M as of Q1 2026.
  • Royal Bank of Canada bought 141,376 Novo Nordisk shares in Q1 2026, an estimated $6.7M.
  • Novo Nordisk made up 0.03% of Royal Bank of Canada's portfolio in Q1 2026, its #457 holding.
  • Royal Bank of Canada first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Novo Nordisk position peaked at $842M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.